Xenetic Biosciences Correlations

XBIOWDelisted Stock  USD 17.54  0.00  0.00%   
The current 90-days correlation between Xenetic Biosciences and BioCardia is -0.01 (i.e., Good diversification). The correlation of Xenetic Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Xenetic Biosciences Correlation With Market

Average diversification

The correlation between Xenetic Biosciences and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xenetic Biosciences and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Moving together with Xenetic Stock

  0.72KB KB Financial GroupPairCorr
  0.71CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.73JPM JPMorgan Chase Sell-off TrendPairCorr
  0.64CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr
  0.86CSCO Cisco Systems Aggressive PushPairCorr
  0.72TRV The Travelers Companies Fiscal Year End 17th of January 2025 PairCorr
  0.78BAC Bank of America Aggressive PushPairCorr
  0.78HPQ HP IncPairCorr
  0.75WMT Walmart Aggressive PushPairCorr
  0.77AXP American Express Fiscal Year End 24th of January 2025 PairCorr
  0.79AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr

Moving against Xenetic Stock

  0.83EC Ecopetrol SA ADRPairCorr
  0.82MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.76TLK Telkom Indonesia TbkPairCorr
  0.7HYMTF Hyundai MotorPairCorr
  0.66SHG Shinhan FinancialPairCorr
  0.62JNJ Johnson Johnson Sell-off TrendPairCorr
  0.59BA Boeing Fiscal Year End 29th of January 2025 PairCorr
  0.51PFE Pfizer Inc Aggressive PushPairCorr
  0.49TCHH Trustcash HoldingsPairCorr
  0.47VFSWW VinFast AutoPairCorr
  0.41WF Woori Financial GroupPairCorr
  0.39MMM 3M Company Fiscal Year End 28th of January 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Xenetic Stock performing well and Xenetic Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xenetic Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Xenetic Biosciences Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xenetic Biosciences stock to make a market-neutral strategy. Peer analysis of Xenetic Biosciences could also be used in its relative valuation, which is a method of valuing Xenetic Biosciences by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Xenetic Biosciences Corporate Executives

Elected by the shareholders, the Xenetic Biosciences' board of directors comprises two types of representatives: Xenetic Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xenetic. The board's role is to monitor Xenetic Biosciences' management team and ensure that shareholders' interests are well served. Xenetic Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xenetic Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.

Still Interested in Xenetic Biosciences?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.